Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke
Haitao Wang, Uma Gaur, Jiao Xiao, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 12, pp. 1745-1754
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Inhibition of PDE4 protects neurons against oxygen-glucose deprivation-induced endoplasmic reticulum stress through activation of the Nrf-2/HO-1 pathway
Bingtian Xu, Yunyun Qin, Dan Li, et al.
Redox Biology (2019) Vol. 28, pp. 101342-101342
Open Access | Times Cited: 100
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Abid Bhat, Bipul Ray, Arehally M. Mahalakshmi, et al.
Pharmacological Research (2020) Vol. 160, pp. 105078-105078
Closed Access | Times Cited: 81
Clinical Implication of Phosphodiesterase-4-Inhibition
Martin A. Schick, Nicolas Schlegel
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1209-1209
Open Access | Times Cited: 48
Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer’s Disease
Jiming Chen, Zhiyuan Zhu, Fu Xu, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 164-164
Open Access | Times Cited: 1
Roflumilast prevents ischemic stroke-induced neuronal damage by restricting GSK3β-mediated oxidative stress and IRE1α/TRAF2/JNK pathway
Bingtian Xu, Jiangping Xu, Ningbo Cai, et al.
Free Radical Biology and Medicine (2020) Vol. 163, pp. 281-296
Closed Access | Times Cited: 65
Phosphodiesterase Type 4 Inhibition in CNS Diseases
Arjan Blokland, Pim R.A. Heckman, Tim Vanmierlo, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 12, pp. 971-985
Open Access | Times Cited: 55
Inhibition of phosphodiesterase: A novel therapeutic target for the treatment of mild cognitive impairment and Alzheimer’s disease
Jianwen Sheng, Shanjin Zhang, Lule Wu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23
Development of White Cabbage, Coffee, and Red Onion Extracts as Natural Phosphodiesterase-4B (PDE4B) Inhibitors for Cognitive Dysfunction: In Vitro and In Silico Studies
Nazir Ahmad, Kaisun Nesa Lesa, Navista Sri Octa Ujiantari, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, pp. 1-39
Open Access | Times Cited: 5
Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review
Pooja Devi Nongthombam, Reena Haobam
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Phosphodiesterase 4 inhibition as a novel treatment for stroke
Jiahong Zhong, Xin Yu, Zhuomiao Lin
PeerJ (2025) Vol. 13, pp. e18905-e18905
Open Access
Unravelling neuroregenerative and neuroprotective roles of Wnt/β-catenin pathway in ischemic stroke: Insights into molecular mechanisms
Srikanth Yadava, Dontiboina Harikrishna Reddy, Venkata Prasuja Nakka, et al.
Neuroscience (2024)
Closed Access | Times Cited: 4
Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Modulation of Cognitive Activity by Plant-Based Extracts (Allium cepa, Coffea robusta, and Brassica oleracea) through the Phosphodiesterase 4B inhibition: Insite from a Mice Model Study
Nazir Ahmad, Kaisun Nesa Lesa, Nanang Fakhrudin, et al.
Phytomedicine Plus (2025), pp. 100778-100778
Open Access
Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein
Jiahong Zhong, Mengfan Li, Jiangping Xu, et al.
Toxicology and Applied Pharmacology (2022) Vol. 436, pp. 115859-115859
Closed Access | Times Cited: 17
A phosphodiesterase 4 (PDE4) inhibitor, amlexanox, reduces neuroinflammation and neuronal death after pilocarpine-induced seizure
Hyun Wook Yang, A Ra Kho, Song Hee Lee, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 4, pp. e00357-e00357
Open Access | Times Cited: 3
Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats
Adel A. Gomaa, Hanan S.M. Farghaly, Asmaa M. Ahmed, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109927-109927
Closed Access | Times Cited: 8
Long Non-coding RNAMALAT1 Knockdown Alleviates Cerebral Ischemia/Reperfusion Injury of Rats Through Regulating the miR-375/PDE4D Axis
Guangjian Zhang, Qingdong Wang, Daoqing Su, et al.
Frontiers in Neurology (2021) Vol. 11
Open Access | Times Cited: 19
Proteomic analysis reveals potential therapeutic targets for childhood asthma through Mendelian randomization
Yiqing Wu, Yixin Cai, Xiaoli Chen, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 2
Inhibition of Phosphodiesterase 4 Suppresses Neuronal Ferroptosis After Cerebral Ischemia/Reperfusion
Kechun Chen, Bingtian Xu, Lu Long, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 2
Inhibition of PDE4 Attenuates TNF-α-Triggered Cell Death Through Suppressing NF-κB and JNK Activation in HT-22 Neuronal Cells
Jiao Xiao, Rumeng Yao, Bingtian Xu, et al.
Cellular and Molecular Neurobiology (2019) Vol. 40, Iss. 3, pp. 421-435
Closed Access | Times Cited: 22
Roflumilast protects against spatial memory impairments and exerts anti‐inflammatory effects after transient global cerebral ischemia
Jéssica Mendes Bonato, Erika Meyer, Patrícia S. B. de Mendonça, et al.
European Journal of Neuroscience (2020) Vol. 53, Iss. 4, pp. 1171-1188
Closed Access | Times Cited: 20
Roflumilast, a cAMP-Specific Phosphodiesterase-4 Inhibitor, Reduces Oxidative Stress and Improves Synapse Functions in Human Cortical Neurons Exposed to the Excitotoxin Quinolinic Acid
Abid Bhat, Vanessa Tan, Benjamin Heng, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 24, pp. 4405-4415
Closed Access | Times Cited: 18
Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement
Xuemei Wei, Guoqi Yu, Hualiang Shen, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106278-106278
Closed Access | Times Cited: 11
Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson’s disease models
Wenli Dong, Jiahong Zhong, Yunqing Chen, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 12, pp. 1991-2003
Open Access | Times Cited: 13
Circ_0101874 overexpression strengthens PDE4D expression by targeting miR-335-5p to promote neuronal injury in ischemic stroke
Liangyan Pei, Xiao-Fan Xu, Tianqi Yuan
Journal of Stroke and Cerebrovascular Diseases (2022) Vol. 31, Iss. 12, pp. 106817-106817
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top